CAR--话题@MedSci

#CAR-#

459篇内容 | 2269人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781265, encodeId=4a1e1e81265a0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【2018 CSH】吴德沛教授：CAR-T 中国应用与发展——在B细胞淋巴瘤治疗领域大放异彩, objectType=article, longId=152389, objectId=410f15238934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=410f15238934, replyNumber=0, likeNumber=75, createdTime=2019-02-27, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=410f15238934, moduleTitle=【2018 CSH】吴德沛教授：CAR-T 中国应用与发展——在B细胞淋巴瘤治疗领域大放异彩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=410f15238934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781217, encodeId=158a1e81217ed, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=PNAS：揭秘CAR-T疗法及副作用路径！有望治疗实体瘤！, objectType=article, longId=129948, objectId=808e1299480e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=808e1299480e, replyNumber=0, likeNumber=70, createdTime=2018-08-06, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=808e1299480e, moduleTitle=PNAS：揭秘CAR-T疗法及副作用路径！有望治疗实体瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=808e1299480e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781218, encodeId=d39e1e81218b9, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？, objectType=article, longId=130441, objectId=33e2130441cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33e2130441cc, replyNumber=0, likeNumber=52, createdTime=2018-04-27, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33e2130441cc, moduleTitle=Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33e2130441cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781240, encodeId=94a51e81240d3, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Gene Therapy：好心帮倒忙，抑癌基因 TET2 或降低 CAR- T 疗效, objectType=article, longId=140825, objectId=6f67140825d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f67140825d2, replyNumber=0, likeNumber=115, createdTime=2018-09-29, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f67140825d2, moduleTitle=Gene Therapy：好心帮倒忙，抑癌基因 TET2 或降低 CAR- T 疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f67140825d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781198, encodeId=a6561e8119874, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=艾森参与美国CAR-T临床肿瘤治疗实际应用专题研讨, objectType=article, longId=121866, objectId=e83712186666, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e83712186666, replyNumber=0, likeNumber=59, createdTime=2018-04-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e83712186666, moduleTitle=艾森参与美国CAR-T临床肿瘤治疗实际应用专题研讨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e83712186666)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781252, encodeId=09d31e8125246, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=施一公、颜宁课题组发表“结构生物学”全新成果、乳腺癌细胞早在胎儿细胞期就已“埋下伏笔”、Nature子刊颁布CAR-T疗法指南……| BioWeek一周事, objectType=article, longId=146455, objectId=e82c14645544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e82c14645544, replyNumber=0, likeNumber=60, createdTime=2018-12-13, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e82c14645544, moduleTitle=施一公、颜宁课题组发表“结构生物学”全新成果、乳腺癌细胞早在胎儿细胞期就已“埋下伏笔”、Nature子刊颁布CAR-T疗法指南……| BioWeek一周事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e82c14645544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781255, encodeId=42aa1e81255a2, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T治疗费用将下降有望颠覆传统癌症治疗, objectType=article, longId=146927, objectId=fb3d14692eb3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb3d14692eb3, replyNumber=0, likeNumber=52, createdTime=2018-12-12, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb3d14692eb3, moduleTitle=CAR-T治疗费用将下降有望颠覆传统癌症治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb3d14692eb3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781242, encodeId=3c351e8124242, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T疗法获得欧盟批准, objectType=article, longId=142300, objectId=995b14230026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=995b14230026, replyNumber=0, likeNumber=73, createdTime=2019-01-31, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=995b14230026, moduleTitle=CAR-T疗法获得欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=995b14230026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781209, encodeId=d1151e8120996, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Biotechnol：CAR-T疗法全新重磅突破！体外T细胞扩增时间有望缩短10倍！, objectType=article, longId=126678, objectId=94cd1266e8aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94cd1266e8aa, replyNumber=0, likeNumber=72, createdTime=2018-11-29, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94cd1266e8aa, moduleTitle=Nat Biotechnol：CAR-T疗法全新重磅突破！体外T细胞扩增时间有望缩短10倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94cd1266e8aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781228, encodeId=90f91e812288d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞疗法和基因治疗能实现可持续销售吗？, objectType=article, longId=135424, objectId=3315135424ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3315135424ff, replyNumber=0, likeNumber=61, createdTime=2018-11-30, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3315135424ff, moduleTitle=CAR-T细胞疗法和基因治疗能实现可持续销售吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3315135424ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781224, encodeId=52b11e81224b0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=从昂贵的CAR-T到看病打车都报销美国医保为啥这么“慷慨”？, objectType=article, longId=134912, objectId=393a13491253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=393a13491253, replyNumber=0, likeNumber=105, createdTime=2018-09-17, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=393a13491253, moduleTitle=从昂贵的CAR-T到看病打车都报销美国医保为啥这么“慷慨”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=393a13491253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781253, encodeId=66951e812535d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=双靶标CAR-T细胞——实体肿瘤的克星, objectType=article, longId=146456, objectId=2b2514645648, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2514645648, replyNumber=0, likeNumber=59, createdTime=2019-04-12, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2514645648, moduleTitle=双靶标CAR-T细胞——实体肿瘤的克星, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b2514645648)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781229, encodeId=33e61e812294f, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Med：CAR-T疗法带来“新惊喜”！有效清除脑肿瘤, objectType=article, longId=135894, objectId=6487135894d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6487135894d2, replyNumber=0, likeNumber=51, createdTime=2018-05-30, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6487135894d2, moduleTitle=Nat Med：CAR-T疗法带来“新惊喜”！有效清除脑肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6487135894d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781208, encodeId=76901e81208ee, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=NEJM：重磅！CAR-T用于治疗淋巴瘤，3年缓解率超70%！, objectType=article, longId=126163, objectId=5e2d126163f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e2d126163f0, replyNumber=0, likeNumber=43, createdTime=2018-09-20, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e2d126163f0, moduleTitle=NEJM：重磅！CAR-T用于治疗淋巴瘤，3年缓解率超70%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e2d126163f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781186, encodeId=16701e8118664, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cell Reports：缺氧，让T细胞抗癌功能更强大！或有助于CAR-T对抗实体瘤, objectType=article, longId=113829, objectId=55021138293f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55021138293f, replyNumber=0, likeNumber=85, createdTime=2018-07-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55021138293f, moduleTitle=Cell Reports：缺氧，让T细胞抗癌功能更强大！或有助于CAR-T对抗实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55021138293f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781245, encodeId=fb731e81245da, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=马军教授：淋巴瘤治疗呈“井喷式”进展，CAR-T治疗引领风骚, objectType=article, longId=142538, objectId=642a142538d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=642a142538d6, replyNumber=0, likeNumber=73, createdTime=2019-01-02, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=642a142538d6, moduleTitle=马军教授：淋巴瘤治疗呈“井喷式”进展，CAR-T治疗引领风骚, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=642a142538d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781221, encodeId=2fe91e812216d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Biotech:重大突破！CAR-T全新升级，抗癌效果至少翻了3倍，还可消除多种实体瘤并预防复发, objectType=article, longId=131688, objectId=e2e41316886b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2e41316886b, replyNumber=0, likeNumber=62, createdTime=2018-10-21, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2e41316886b, moduleTitle=Nat Biotech:重大突破！CAR-T全新升级，抗癌效果至少翻了3倍，还可消除多种实体瘤并预防复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2e41316886b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781222, encodeId=0d281e8122247, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Biotechnol：实体瘤轻松被KO，新一代CAR-T显神威, objectType=article, longId=131741, objectId=6e29131e4112, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e29131e4112, replyNumber=0, likeNumber=51, createdTime=2018-04-21, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e29131e4112, moduleTitle=Nat Biotechnol：实体瘤轻松被KO，新一代CAR-T显神威, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e29131e4112)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781182, encodeId=7e1d1e8118223, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=什么情况？CAR-T疗法临床研究被FDA叫停, objectType=article, longId=112279, objectId=31881122e9ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31881122e9ce, replyNumber=0, likeNumber=64, createdTime=2017-09-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31881122e9ce, moduleTitle=什么情况？CAR-T疗法临床研究被FDA叫停, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31881122e9ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781169, encodeId=2d7c1e81169e6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=全球CAR-T疗法上市在即中国市场格局悄然发生变化, objectType=article, longId=106673, objectId=6a851066e316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a851066e316, replyNumber=0, likeNumber=56, createdTime=2018-05-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a851066e316, moduleTitle=全球CAR-T疗法上市在即中国市场格局悄然发生变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a851066e316)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

CAR-

2020-05-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

【2018 CSH】吴德沛教授：CAR-T 中国应用与发展——在B细胞淋巴瘤治疗领域大放异彩

2019-02-27

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

PNAS：揭秘CAR-T疗法及副作用路径！有望治疗实体瘤！

2018-08-06

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Leukemia：难治性或复发性B-ALL：低剂量CD19-CAR-T细胞疗法有效吗？

2018-04-27

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Gene Therapy：好心帮倒忙，抑癌基因 TET2 或降低 CAR- T 疗效

2018-09-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

艾森参与美国CAR-T临床肿瘤治疗实际应用专题研讨

2018-04-06

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

施一公、颜宁课题组发表“结构生物学”全新成果、乳腺癌细胞早在胎儿细胞期就已“埋下伏笔”、Nature子刊颁布CAR-T疗法指南……| BioWeek一周事

2018-12-13

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T治疗费用将下降有望颠覆传统癌症治疗

2018-12-12

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T疗法获得欧盟批准

2019-01-31

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nat Biotechnol：CAR-T疗法全新重磅突破！体外T细胞扩增时间有望缩短10倍！

2018-11-29

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞疗法和基因治疗能实现可持续销售吗？

2018-11-30

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

从昂贵的CAR-T到看病打车都报销美国医保为啥这么“慷慨”？

2018-09-17

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

双靶标CAR-T细胞——实体肿瘤的克星

2019-04-12

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nat Med：CAR-T疗法带来“新惊喜”！有效清除脑肿瘤

2018-05-30

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

NEJM：重磅！CAR-T用于治疗淋巴瘤，3年缓解率超70%！

2018-09-20

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cell Reports：缺氧，让T细胞抗癌功能更强大！或有助于CAR-T对抗实体瘤

2018-07-08

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

马军教授：淋巴瘤治疗呈“井喷式”进展，CAR-T治疗引领风骚

2019-01-02

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nat Biotech:重大突破！CAR-T全新升级，抗癌效果至少翻了3倍，还可消除多种实体瘤并预防复发

2018-10-21

仁心济世 (审核中...)

前往app查看评论内容

#CAR-#

Nat Biotechnol：实体瘤轻松被KO，新一代CAR-T显神威

2018-04-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

什么情况？CAR-T疗法临床研究被FDA叫停

2017-09-30

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

全球CAR-T疗法上市在即中国市场格局悄然发生变化

2018-05-25

科室
- - 订阅+
  - 更多科室
工具
服务